Xeljanz Cancer Risks Detailed
The degree to which the oral rheumatology drug tofacitinib (Xeljanz) seems to promote new…
Browsing Tag
Tofacitinib
Tofacitinib shows promise in scleroderma patients, researchers optimistic for next…
Systemic sclerosis -- or scleroderma that affects the skin and internal organs -, is one of the rarest autoimmune diseases, affecting roughly 100,000 people (primarily women) in the United…
CV, Cancer Risk Up With Tofacitinib for Rheumatoid Arthritis
FRIDAY, Jan. 28, 2022 (HealthDay News) -- For patients…
FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risks
The FDA has finished its review of a large postmarketing safety study of tofacitinib (Xeljanz,…
Arthritis Drug Down Risk of death in Severe COVID Patients
The efficacy of Tofacitinib was tested on 289 patients hospitalised with severe Covid across 15 locations in Brazil. Half of these patients received 10 mg twice daily plus standard of care…